Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions-Reference-Cited by-同舟云学术

Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions

Published:2003-08 Issue:2 Volume:146 Page:345-350
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Best Patricia J.M,Lennon Ryan,Gersh Bernard J,Ting Henry H,Rihal Charanjit S,Bell Malcolm R,Herzog Charles A,Holmes David R,Berger Peter B

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?;Rubenstein;Circulation,2000

2. Even mild renal insufficiency is associated with increased mortality after percutaneous coronary interventions [abstract];Best;J Am Coll Cardiol,2001

3. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994;330:956–61

4. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997;336:1689–96

5. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997;349:1429–35

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and predictors of groin complications early after coronary artery intervention: a prospective observational study;BMC Nursing;2019-06-28

2. Diagnosis and treatment of myocardial infarction in patient with end - stage renal disease on chronic hemodialysis;Terapevticheskii arkhiv;2019-06-15

3. Antiplatelet Therapy;Cardiac Intensive Care;2019

4. The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium;Catheterization and Cardiovascular Interventions;2017-03-17

5. Precision Subtypes of T Cell-Mediated Rejection Identified by Molecular Profiles;Frontiers in Immunology;2015-11-06